JAMA Network Open
Bladder drugs presumed safer not linked to lower dementia risk
Estimated 10-year dementia risk was 20.0% with mirabegron or vibegron, compared with 18.1% with drugs classified as high-risk anticholinergics.Estimated 10-year dementia risk was 20.0% with mirabegron or vibegron, compared with 18.1% with drugs classified as high-risk anticholinergics.

Cohort · 830,393 peopleIncident dementia
Who was studied830,393 adults with overactive bladder, up to 10 years, against β3 agonist users
What changedDementia risk was lower with high-risk anticholinergics than with β3 agonists (hazard ratio 0.90)
The catchPreferential prescribing of β3 agonists to cognitively vulnerable patients could explain their higher dementia risk



